Published in Int J Drug Policy on August 10, 2012
Fire in the vein: Heroin acidity and its proximal effect on users' health. Int J Drug Policy (2015) 2.13
Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume. PLoS One (2015) 1.41
Could low dead-space syringes really reduce HIV transmission to low levels? Int J Drug Policy (2012) 1.00
Next-generation sequencing reveals large connected networks of intra-host HCV variants. BMC Genomics (2014) 0.92
Evidence of injection drug use in Kisumu, Kenya: Implications for HIV prevention. Drug Alcohol Depend (2015) 0.88
Saying goodbye to high-dead-space syringes. Int J Drug Policy (2012) 0.88
Low Dead-Space Syringes for HIV prevention among people who inject drugs: interesting, but a much stronger case is required. Int J Drug Policy (2012) 0.87
How to encourage use of low dead space syringes? The Viet Nam experience. Int J Drug Policy (2012) 0.86
Are you HIV invincible? A probabilistic study of discordant couples in the context of HIV transmission. PLoS One (2014) 0.86
Implementation of low dead-space syringes needs consultation and engagement with drug users. Int J Drug Policy (2012) 0.85
Dead space: a risk factor we did not see. Int J Drug Policy (2012) 0.85
Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan. Harm Reduct J (2015) 0.79
Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City. Harm Reduct J (2015) 0.77
Prevalence and correlates of needle-stick injuries among active duty police officers in Tijuana, Mexico. J Int AIDS Soc (2016) 0.77
Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs. Am J Public Health (2015) 0.75
Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes. AIDS Res Hum Retroviruses (2016) 0.75
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73
Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001. AIDS (2003) 5.88
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. Sex Transm Infect (2010) 3.14
Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One (2008) 2.31
Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One (2010) 2.30
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Back to basics in HIV prevention: focus on exposure. BMJ (2003) 1.99
Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One (2011) 1.98
The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One (2009) 1.97
What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect (2010) 1.92
Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS (2009) 1.60
Estimates of HIV incidence from household-based prevalence surveys. AIDS (2010) 1.59
Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy. Sex Transm Infect (2010) 1.59
Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS One (2011) 1.56
Methods used in the Lives Saved Tool (LiST). BMC Public Health (2011) 1.48
Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31. Lancet (2010) 1.46
Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults. Sex Transm Infect (2010) 1.45
The estimated burden of HIV/AIDS in Uganda, 2005-2010. AIDS (2008) 1.34
Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff (Millwood) (2009) 1.33
Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol (2008) 1.31
The past, present and future of HIV, AIDS and resource allocation. BMC Public Health (2009) 1.24
Estimation of antiretroviral therapy coverage: methodology and trends. Curr Opin HIV AIDS (2010) 1.21
The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV. AIDS (2014) 1.18
Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries. AIDS Res Treat (2011) 1.15
Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ (2012) 1.14
An age-structured model for the potential impact of generalized access to antiretrovirals on the South African HIV epidemic. Bull Math Biol (2010) 1.07
Estimating future trends in paediatric HIV. AIDS (2014) 1.07
Changes in the distribution of high-risk births associated with changes in contraceptive prevalence. BMC Public Health (2013) 1.05
The cost and impact of male circumcision on HIV/AIDS in Botswana. J Int AIDS Soc (2009) 1.02
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS (2014) 1.01
Where are the gaps? The effects of HIV-prevention interventions on behavioral change. Stud Fam Plann (2004) 1.01
Under-5 mortality due to HIV: regional levels and 1990-2009 trends. Sex Transm Infect (2010) 0.99
Estimating the impact of reducing violence against female sex workers on HIV epidemics in Kenya and Ukraine: a policy modeling exercise. Am J Reprod Immunol (2013) 0.91
Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV. PLoS One (2010) 0.91
Redefining the HIV epidemic in Nigeria: from national to state level. AIDS (2014) 0.90
The effect of heterogeneity on HIV prevention trials. Clin Trials (2011) 0.90
Embracing different approaches to estimating HIV incidence, prevalence and mortality. AIDS (2014) 0.88
The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand. Vaccine (2011) 0.87
Improving estimates of children living with HIV from the Spectrum AIDS Impact Model. AIDS (2017) 0.87
Modelling the potential impact and cost of scaling-up male circumcision in resource poor settings: A case of Uganda. Afr J AIDS Res (2013) 0.86
Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery. Transfusion (2012) 0.86
On the relationship between age, annual rate of infection, and prevalence of mycobacterium tuberculosis in a South African township. Clin Infect Dis (2009) 0.86
Using HIV surveillance data: recent experiences and avenues for the future. AIDS (2005) 0.83
Family planning programs in 2004: new assessments in a changing environment. Int Fam Plan Perspect (2007) 0.82
Modelling the demographic impact of AIDS. J Health Popul Nutr (2002) 0.81
Antiretroviral therapy needs: the effect of changing global guidelines. Sex Transm Infect (2010) 0.77
Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation. Anesthesiology (2005) 0.77
Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe. AIDS (2017) 0.76
Low dead space syringes: authors' response. Int J Drug Policy (2012) 0.75
Correction: Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program. PLoS One (2016) 0.75
Putting the burden of HIV in context. AIDS (2013) 0.75
Correction: Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0. PLoS One (2017) 0.75
Dismissal of the utility of free cortisol measurement is premature. Intensive Care Med (2012) 0.75
Linking high parity and maternal and child mortality: what is the impact of lower health services coverage among higher order births? BMC Public Health (2013) 0.75
Correction: What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One (2016) 0.75
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis. Clin Chem Lab Med (2016) 0.75
Improvements in Spectrum's fit to program data tool. AIDS (2017) 0.75
Resource requirements to fight HIV/AIDS in Latin America and the Caribbean. AIDS (2002) 0.75
Is scaling up enough to curb the HIV epidemic in southern Africa? S Afr Med J (2009) 0.75
30 years after HIV identification: where to from here? Expert Rev Anti Infect Ther (2011) 0.75
Progress toward the Goals of FP2020. Stud Fam Plann (2017) 0.75
The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration. Crit Care Resusc (2013) 0.75